Dormant
BLKB · Blackbaud, Inc.
Last analysed ·
Current thesis
Blackbaud’s repurchase-led recovery needs sustained 3.0% organic growth and a weekly close above $47.52 by Q3 results. The $45.48 close on 2026-09-11 leaves that case unconfirmed; a weekly close below $44 invalidates it.
Kill line
A weekly close below $44 breaks the post-Q2 recovery structure. Organic revenue growth below the Q2 2026 rate of 3.0%, or a cut to the $1.173 billion–$1.179 billion 2026 revenue guidance affirmed on 2026-07-29, separately contradicts the operating premise.
Pick status
Open commitment catalyst 5d agoscored if the kill line above fires How this is scored →Latest analysis and events for BLKB —
As of 13 September 2026, the latest FrontierPicks analysis for Blackbaud, Inc. (BLKB): Blackbaud’s repurchase-led recovery needs sustained 3.0% organic growth and a weekly close above $47.52 by Q3 results. The $45.48 close on 2026-09-11 leaves that case unconfirmed; a weekly close below $44 invalidates it.
Kill line: A weekly close below $44 breaks the post-Q2 recovery structure. Organic revenue growth below the Q2 2026 rate of 3.0%, or a cut to the $1.173 billion–$1.179 billion 2026 revenue guidance affirmed on 2026-07-29, separately contradicts the operating premise.
Most recent dated event on file: — catalyst 5d ago.
Current Thesis
Blackbaud’s repurchase-led recovery needs sustained revenue growth and a recovery above its August closing reference; a weekly close below $44 would invalidate the price thesis. The adjusted close fell to $45.48 on 2026-09-11 from $47.10 on 2026-09-04, bringing the market back toward the $45.45 daily close recorded on 2026-08-11. These are measured price observations; attributing the recovery to repurchases remains an inference.
The narrative is maturing — the 2026-07-29 earnings case now faces weaker price momentum, while Argus’s quantitative report dated 2026-09-09 lowered its target to $48. That report establishes a fresh downward target revision; its accessible summary does not explain the change. Argus report
The earlier description of an empty catalyst calendar needs correction: Blackbaud lists a September investor conference and has announced bbcon for September 29–October 1. Neither event is an announced earnings release. The newsroom reviewed on 2026-09-13 still displayed 2026-09-02 as its latest announcement. Investor calendar, bbcon announcement, company newsroom
Bullish and bearish views on Blackbaud, Inc.
The model's bull view on Blackbaud, Inc. (BLKB), in brief: Repurchases remain a documented support. The bear view: Revenue missed the reported estimate. Benzinga’s 2026-07-29 earnings headline reported Q2 revenue of $290.597 million against a $292.303 million estimate, despite adjusted earnings per share of $1.33 exceeding the $1.28 estimate. The earnings beat therefore did not establish… Both cases follow in full.
Bull Case
- Repurchases remain a documented support. On 2026-07-29, management reported repurchasing just over 6% of shares year to date; approximately $850 million of authorization remained at 2026-06-30. Authorization establishes capacity, not subsequent execution. Q2 release
- Recurring revenue supports operating continuity. Q2 2026 recurring revenue was $285.3 million, representing 98.2% of total revenue; organic revenue grew 3.0% year over year. These measurements support continuity but do not establish accelerating growth across multiple quarters. 2026-07-29 results
- Management retained its financial outlook. On 2026-07-29, Blackbaud affirmed 2026 revenue guidance of $1.173 billion–$1.179 billion and adjusted diluted earnings per share of $5.15–$5.25, with upper-half expectations. These remain management forecasts. Q2 outlook
Bear Case
- Revenue missed the reported estimate. Benzinga’s 2026-07-29 earnings headline reported Q2 revenue of $290.597 million against a $292.303 million estimate, despite adjusted earnings per share of $1.33 exceeding the $1.28 estimate. The earnings beat therefore did not establish revenue outperformance.
- The latest target revision declined. Argus’s 2026-09-09 quantitative report lowered its Blackbaud target to $48. The earlier $48.50 consensus observation was dated August and does not establish a current valuation ceiling. Argus report
Setup & Price Structure
At the 2026-09-11 adjusted close of $45.48, the shares had gained 63.0% over three months but remained 35.2% below the $70.17 high in the supplied 52-week series. The 14-day relative strength index (RSI) was 40.7, versus 67.4 on 2026-09-04. This combination supports an inference of weakening momentum within the larger recovery; it does not establish a completed base.
The $45.45 close on 2026-08-11 is a daily reference, not a weekly closing observation. The published $44 weekly threshold remains the thesis-break condition. A weekly close above the $47.52 closing reference dated 2026-08-21 would establish a measurable price recovery; the latest snapshot cannot establish what happened in every intervening session.
The previously documented Form 4 disclosures record officer sales by Kevin Gregoire on 2026-08-06, Michael Gianoni on 2026-08-25, David Benjamin on 2026-08-31 and Chad Anderson on 2026-09-01. These establish insider selling during the recovery, not the sellers’ motives or aggregate investor crowding. Current short-interest, retail-participation and moving-average measurements are missing; no crowding conclusion follows.
Catalyst Calendar (next 30 days)
- 2026-09-29–2026-10-01: bbcon in Columbus. Blackbaud announced these dates on 2026-03-26. Product announcements would establish development progress; commercial adoption would require separately disclosed customer or revenue evidence. Company announcement
- ~2026-10-28, estimated: Q3 2026 results. This later event is the operating test of the thesis. Stock Analysis lists this date, but company confirmation was not located as of 2026-09-13. The relevant disclosures are organic growth, annual guidance and actual repurchases. Earnings calendar
Elapsed catalysts
- 2026-09-15–2026-09-16: Piper Sandler Growth Frontiers Conference. Blackbaud’s investor page lists participation. The event provides an opportunity for financial commentary, but the listing promises no guidance update. Investor calendar (passed 4d ago)
What Would Change Our Mind
Loss of the post-Q2 price structure would end the recovery case: a weekly close below $44 is the published invalidation condition. Organic growth below the Q2 2026 rate of 3.0%, or a reduction to the revenue range affirmed on 2026-07-29, would separately contradict its operating premise.
For grading, the recovery case requires a weekly close above $47.52 by the Q3 release, alongside organic growth of at least 3.0% and retention of the July revenue guidance, before the $44 invalidation occurs. Failure to meet those conditions by the release would leave the case unfulfilled even if the price threshold remained intact. The weaker 2026-09-11 momentum reading supports a low-conviction forecast.
Correlation Notes
This remains a single-company setup. Blackbaud’s newsroom records a Raiser’s Edge NXT integration with Microsoft 365 Copilot on 2026-08-10, correcting the earlier uncertainty about a company announcement. That establishes a product connection to artificial intelligence software; it does not establish incremental revenue or correlated share-price performance. Company newsroom
No paired return series or sector-flow measurements accompany the 2026-09-11 price snapshot. The evidence therefore supports neither a measured software-sector correlation nor a claim that an artificial intelligence group rally explains Blackbaud’s recovery.
Notes
- Blackbaud pays no dividend; all shareholder return runs through the repurchase program, so buyback pace and capital-return risk are one variable.
- Q2 FY26 revenue was 98.2% recurring, so quarterly revenue surprises are small; variance shows up in bookings and renewal commentary on the call.
- A limited-duration shareholder rights plan was adopted in 2024 after the Clearlake proposal was rejected; its expiry is not confirmed in publicly reviewed sources.
- The 2020 security incident produced regulatory settlements disclosed in prior filings; current 10-K risk factors should be checked for residual claims.
- Aggregator 52-week ranges quote $25.58-$70.71; the adjusted daily series used for levels here shows a $70.17 high, so cross-source comparisons differ slightly.
Related · shared themes
APPN
Appian Corporation
Appian’s AI orchestration re-rating needs Q3 revenue of at least $214 million and cloud subscriptions of at least $133 million to confirm management’s August guidance. A weekly close below $34 or a miss against either revenue floor invalidates the case.
CRM
Salesforce, Inc.
De-rated Dow software incumbent on two dated legs: the $1.6B VA agentic ELA (2026-07-24) and Reuters' 2026-08-13 report of Silver Lake–Workday take-private talks, which put a private-market floor under mega-cap SaaS. Six target revisions between 2026-08-12 and 2026-08-20 chased price to $209.17; the 2026-08-26 Q2 FY27 print is the binary and much of the discount closed before it.
CRWD
CrowdStrike Holdings, Inc.
Fal.Con (2026-08-31 to 09-03) delivered real product — Falcon Guardian, Falcon IQ, GPT-5.6 Cyber in Falcon, Anthropic marketplace distribution — and nine broker actions through 2026-09-04 including Truist $300, yet CRWD closed $213.10 on 2026-09-04, below the $218.40 of 08-28 and the $233.88 range high. The catalyst is spent and no company-dated event lands before the ~2026-12-02 Q3 print, leaving a maturing narrative carried by targets rather than a widening bid.
FROG
JFrog Ltd.
Software-supply-chain-security plus AI-agent "trust layer" narrative keeps re-rating: the analyst cluster now leads price above $100 (UBS Buy $110 Jul 2, Truist Buy $105 Jul 9), confirming the continuation tell flagged in June. Fundamentals accelerating (Q1 rev +26%, security 10% of ARR), but a fresh long is extended near 52-week highs with the ~Aug 6 Q2 print the next binary.